Rafferty Asset Management, LLC Agenus Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $272,185 - $456,883	243,023 Added 16.9%	1,680,974 $1.9 Million
Q2 2023 Aug 11, 2023	SELL	$1.31 - $2.04 $974,060 - $1.52 Million	-743,558 Reduced 34.08%	1,437,951 $2.3 Million
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $625,921 - $1.27 Million	431,670 Added 24.67%	2,181,509 $3.32 Million
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $717,437 - $1.15 Million	355,167 Added 25.47%	1,749,839 $4.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $804,597 - $1.29 Million	410,509 Added 41.71%	1,394,672 $2.86 Million
Q2 2022 Aug 12, 2022	SELL	$1.3 - $2.64 $238,032 - $483,389	-183,102 Reduced 15.69%	984,163 $1.91 Million
Q1 2022 May 13, 2022	SELL	$2.35 - $3.47 $1.11 Million - $1.63 Million	-470,373 Reduced 28.72%	1,167,265 $2.87 Million
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $3.38 Million - $6.65 Million	1,158,245 Added 241.61%	1,637,638 $5.27 Million
Q3 2021 Nov 10, 2021	BUY	$4.98 - $6.63 $297,460 - $396,016	59,731 Added 14.23%	479,393 $2.52 Million
Q2 2021 Aug 10, 2021	SELL	$2.56 - $5.49 $593,500 - $1.27 Million	-231,836 Reduced 35.59%	419,662 $2.3 Million
Q1 2021 May 10, 2021	BUY	$2.69 - $5.25 $1.46 Million - $2.85 Million	542,399 Added 497.16%	651,498 $1.77 Million
Q4 2020 Feb 10, 2021	SELL	$3.17 - $4.49 $156,420 - $221,554	-49,344 Reduced 31.14%	109,099 $347,000
Q3 2020 Nov 13, 2020	BUY	$2.98 - $5.2 $267,416 - $466,632	89,737 Added 130.61%	158,443 $634,000
Q2 2020 Aug 07, 2020	BUY	$2.29 - $4.24 $157,336 - $291,313	68,706 New	68,706 $270,000
Q1 2020 May 15, 2020	SELL	$1.92 - $4.39 $146,899 - $335,878	-76,510 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$2.41 - $4.4 $184,389 - $336,644	76,510 New	76,510 $311,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account